Meet Polyplus during the DNA Process Development & Manufacturing in Boston, US on 5th - 7th March 2024.

Our team

DNA Process development & manufacturing, three full days of exclusive information on plasmid-based DNA production, plus a day of in-depth workshops led by AskBio and Janssen R&D experts, focused on navigating the regulatory landscape and optimizing manufacturing strategies. Don’t miss 7 hours of networking opportunities to meet peers from process development and manufacturing functions.

Discover Our Applications

Cell & Gene Therapy

Success of Gene and Cell Therapies is dependent on efficient production of viral vectors that require optimized transfection reagents and viral vector engineering

RNA/DNA Therapeutics

RNA/DNA in vivo delivery is the most powerful alternative to viral vectors for nucleic acid-based therapies. They offer substantial advantages in terms of reliability,safety and costs for nucleic-acid based therapies

Protein Production

Broad range of solutions is needed for manufacturing of functional  proteins or antibodies at the desired scale in bacteria, yeast and mammalian cell expression systems

Life Sciences

Optimised plasmid engineering and specific transfection reagents are key to enable protein expression in a wide range of adherent and suspension mammalian cell types